.png){kind=icon}
返回
李
李铮 (Zheng Li)
Department of Radiotherapy
57H指数
430论文数
1.0W被引数
收录论文 135
发表时间
.png){kind=icon}
A phase 2 trial of a “sandwich” strategy: Sequential CD22/CD19 chimeric antigen receptor T-cells therapy combined with autologous hematopoietic stem cell transplantation in patients with Philadelphia chromosome–negative B-cell acute lymphoblastic leukemia一项“夹心”策略的2期临床试验：序贯CD22/CD19嵌合抗原受体T细胞疗法联合自体造血干细胞移植治疗费城染色体阴性B细胞急性淋巴细胞白血病患者.png)
Cancer.png)
OAAI
CancerIF5.1
OAAI.png){kind=icon}
分享.png){kind=icon}
收藏Successful Pregnancy and Healthy Baby Outcome in a Patient With Tyrosine Kinase Inhibitor–Refractory ALK-Positive NSCLC and Central Nervous System Metastasis Treated With Lorlatinib With Maternal-Fetal Pharmacokinetics and Child Milestone Development Correlations在一名对酪氨酸激酶抑制剂耐药的ALK阳性非小细胞肺癌伴中枢神经系统转移患者中，接受洛拉替尼治疗后实现成功妊娠和健康婴儿结局，并分析其母胎药代动力学及儿童发育里程碑的相关性。OAAI
OAAI分享收藏